UBS O'Connor’s Cubist Pharmaceuticals CBST Stock Holding History
Bought
Maintained
Sold
UBS O'Connor's CBST Position: Q1 2015 in Review
UBS O'Connor sold out of Cubist Pharmaceuticals (CBST) in Q1 2015, closing a stake of 592,729 shares — an estimated $59.7M sold.
UBS O'Connor first reported a position in CBST in Q2 2014 and held it in 2 quarters. The position peaked at $59.7M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.
- UBS O'Connor reported no remaining Cubist Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
- UBS O'Connor sold 592,729 Cubist Pharmaceuticals shares in Q1 2015, an estimated $59.7M.
- UBS O'Connor first reported a position in Cubist Pharmaceuticals in Q2 2014 and held it in 2 quarters.
- UBS O'Connor's Cubist Pharmaceuticals position peaked at $59.7M in Q4 2014.
- 0 funds tracked by Wall St. Rank held Cubist Pharmaceuticals as of Q1 2015.
Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.